Latest news
Loading news…
Clinilabs
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2001 101-250 employees For Profit
Clinilabs is a research company specializing in clinical development services.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
143
Patents
1
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 20
- Active products
- 24
- Patents granted
- 1
- Trademarks
- 1
- Top patent class
- Computing; Calculating
- IT spend
- $2M
Company Info
- Founded
- 2001
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 11
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 3.4
- Trend (90d)
- 0.1
- Last leadership hire
- Feb 24, 2026
Key People at Clinilabs
President and Chief Executive Officer
Executive Vice President and Head of Clinilabs Europe
143
professional contacts at Clinilabs
Contact execs at Clinilabs →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Clinilabs
Loading news…
FAQs about Clinilabs
People who checked this page also checked these
Browse the full Acquirezy directory.